Clinical trial
Effects of a Combined TMS Stimulation and Cognitive Training in Alzheimer Patients: a Single-center, Randomized, Double-blind, Placebo-controlled Study
NCT01168245 is registered in ClinicalTrials.gov with Neuronix Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of a Combined TMS Stimulation and Cognitive Training in Alzheimer Patients: a Single-center, Randomized, Double-blind, Placebo-controlled Study
- Lead sponsor
- Neuronix Ltd
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- September 30, 2011
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, mild to moderate